Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
Provided By GlobeNewswire
Last update: Nov 19, 2024
INTEGRIS-PSC featured in an oral late breaker presentation
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the presentation of clinical data at The Liver Meeting® 2024 of the American Association for the Study of Liver Diseases (AASLD) being held in San Diego, California.
Read more at globenewswire.com3.08
+0.07 (+2.33%)
Find more stocks in the Stock Screener
PLRX Latest News and Analysis
10 days ago - ChartmillUnusual volume stocks in Wednesday's sessionDiscover the stocks with unexpected trading volume in today's session on the US markets.
12 days ago - ChartmillWhich stocks are experiencing notable movement on Monday?Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
12 days ago - ChartmillLet's have a look at the top gainers and losers in the middle of the day of today's session.Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
12 days ago - ChartmillThe market is filled with gapping stocks in Monday's session.Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
12 days ago - ChartmillMonday's pre-market session: top gainers and losersDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.
